Cubist Systematic Strategies’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$1.43M Buy
17,400
+4,100
+31% +$323K 0.01% 1759
2025
Q2
$1.07M Buy
13,300
+1,600
+14% +$123K ﹤0.01% 1908
2025
Q1
$939K Buy
11,700
+2,100
+22% +$175K 0.01% 1854
2024
Q4
$786K Buy
9,600
+7,200
+300% +$599K ﹤0.01% 1943
2024
Q3
$198K Sell
2,400
-166,900
-99% -$12.5M ﹤0.01% 2572
2024
Q2
$11.9M Buy
169,300
+133,500
+373% +$9.53M 0.08% 333
2024
Q1
$2.65M Sell
35,800
-39,200
-52% -$2.73M 0.02% 1420
2023
Q4
$4.96M Sell
75,000
-156,500
-68% -$9.79M 0.03% 885
2023
Q3
$14.6M Sell
231,500
-67,900
-23% -$4.23M 0.11% 212
2023
Q2
$16.9M Buy
299,400
+273,700
+1,065% +$15.2M 0.11% 170
2023
Q1
$1.49M Sell
25,700
-7,800
-23% -$526K 0.01% 1874
2022
Q4
$2.42M Buy
33,500
+18,900
+129% +$1.35M 0.01% 1689
2022
Q3
$887K Hold
14,600
0.01% 2719
2022
Q2
$917K Buy
+14,600
New +$966K 0.01% 2548

Other funds holding MET

Cubist Systematic Strategies's MET Position: Q3 2025 in Review

Cubist Systematic Strategies sold out of MetLife (MET) in Q3 2025, closing a stake of 499,021 shares — an estimated $39.3M sold.

Cubist Systematic Strategies first reported a position in MET in Q2 2014 and held it in 42 quarters. The position peaked at $40.1M in Q2 2025. 1,363 funds tracked by Wall St. Rank hold MET as of Q3 2025.

  • Cubist Systematic Strategies reported no remaining MetLife position as of Q3 2025 after selling out during the quarter.
  • Cubist Systematic Strategies sold 499,021 MetLife shares in Q3 2025, an estimated $39.3M.
  • Cubist Systematic Strategies first reported a position in MetLife in Q2 2014 and held it in 42 quarters.
  • Cubist Systematic Strategies's MetLife position peaked at $40.1M in Q2 2025.
  • 1,363 funds tracked by Wall St. Rank held MetLife as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.